Search details
1.
Immunosuppressive therapy management in cancer patients with autoimmune diseases treated with immune checkpoint inhibitors: A case series and systematic literature review.
J Oncol Pharm Pract
; 30(1): 55-66, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37051622
2.
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
Cancer Immunol Immunother
; 72(2): 475-491, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-35960332
3.
Durvalumab-induced thyroiditis in a patient with non-small cell lung carcinoma: a case report and review of pathogenic mechanisms.
BMC Endocr Disord
; 22(1): 291, 2022 Nov 22.
Article
in English
| MEDLINE | ID: mdl-36419114
4.
Understanding genetic determinants of resistance to immune checkpoint blockers.
Semin Cancer Biol
; 65: 123-139, 2020 10.
Article
in English
| MEDLINE | ID: mdl-31881338
5.
How to assimilate the tsunami of immune checkpoints inhibitors data into clinical practice?
Curr Opin Oncol
; 31(5): 420-423, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31335831
6.
Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?
Curr Opin Oncol
; 31(2): 54-64, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30694841
7.
PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer.
BMC Cancer
; 19(1): 506, 2019 May 28.
Article
in English
| MEDLINE | ID: mdl-31138229
8.
Importance of choice of materials and methods in PD-L1 and TIL assessment in oropharyngeal squamous cell carcinoma.
Histopathology
; 73(3): 500-509, 2018 Sep.
Article
in English
| MEDLINE | ID: mdl-29768723
9.
Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas.
Anticancer Drugs
; 28(3): 341-349, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27977433
10.
Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors.
Anticancer Drugs
; 27(10): 1021-7, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27610894
11.
CD70 Expression and Its Correlation with Clinicopathological Variables in Squamous Cell Carcinoma of the Head and Neck.
Pathobiology
; 83(6): 327-33, 2016.
Article
in English
| MEDLINE | ID: mdl-27389010
12.
Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis.
EMBO J
; 30(11): 2294-305, 2011 Jun 01.
Article
in English
| MEDLINE | ID: mdl-21552205
13.
Synthesis of C-5â³ and C-6â³-modified α-GalCer analogues as iNKT-cell agonists.
Bioorg Med Chem
; 23(13): 3175-82, 2015 Jul 01.
Article
in English
| MEDLINE | ID: mdl-26003341
14.
Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells.
J Immunol
; 191(5): 2174-83, 2013 Sep 01.
Article
in English
| MEDLINE | ID: mdl-23898038
15.
Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection.
J Immunol
; 191(6): 2916-25, 2013 Sep 15.
Article
in English
| MEDLINE | ID: mdl-23960235
16.
Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy.
Ann Rheum Dis
; 77(3): 468-470, 2018 03.
Article
in English
| MEDLINE | ID: mdl-28242618
17.
Steroid-dependent pericarditis following anti-PD1 immunotherapy in a metastatic melanoma patient: a case report.
Eur Heart J Case Rep
; 7(3): ytad112, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36937234
18.
Systemic treatment and radiotherapy for patients with non-small cell lung cancer (NSCLC) and HIV infection - A systematic review.
Lung Cancer
; 178: 75-86, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36806897
19.
Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus.
Eur J Cancer
; 187: 36-57, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37116287
20.
Recommendations of the International Society of Geriatric Oncology on skin cancer management in older patients.
J Geriatr Oncol
; 14(4): 101502, 2023 05.
Article
in English
| MEDLINE | ID: mdl-37080793